Off-Label Use of Drug-Eluting Stents: Putting it in Perspective
- 12 February 2008
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 51 (6) , 615-617
- https://doi.org/10.1016/j.jacc.2007.10.028
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarctionEuropean Heart Journal, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsJournal of the American College of Cardiology, 2007
- Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent RestenosisJournal of the American College of Cardiology, 2006
- Off‐Label Use: An Industry Perspective on Expanding Use Beyond Approved IndicationsJournal of Interventional Cardiology, 2006
- Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II)Circulation, 2006
- Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents: Pooled Analysis of Five Clinical TrialsJournal of the American College of Cardiology, 2006
- On- Versus Off-Label Use of Drug-Eluting Coronary Stents in Clinical Practice (Report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])The American Journal of Cardiology, 2006
- The Year in Interventional CardiologyJournal of the American College of Cardiology, 2006
- The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) TrialJournal of the American College of Cardiology, 2006
- The year in interventional cardiologyJournal of the American College of Cardiology, 2005